The best-funded idea in biology right now is that aging can be run backward.
The thesis traces to Shinya Yamanaka, who showed that four transcription factors, Oct4, Sox2, Klf4, and c-Myc, can return an adult cell to an embryonic state and erase both its identity and its age. The rejuvenation field keeps the age reset and drops the identity reset: express the factors briefly and partially, and you can wind a cell's biological age down without turning it back into a stem cell. In prematurely aged mice, cyclic partial reprogramming ameliorates the hallmarks of aging and extends lifespan. In the eye, a three-factor cocktail called OSK restored youthful DNA-methylation patterns and reversed vision loss in a mouse model of glaucoma. That work is now cleared for the clinic: in January 2026 the FDA granted an IND for Life Biosciences' ER-100, the first partial-reprogramming therapy allowed into human trials, a Phase 1 study testing safety in optic neuropathy. Altos Labs, the best-capitalized company in the field, is chasing the same biology.
Every one of those results is scored on an epigenetic clock: a DNA-methylation signature that reads out biological age. Reset the methylation, you reset the clock. Hold that against fifteen years of my own work, and the overlap is exact. I have spent that time building the published-limits infrastructure for one of the most thoroughly documented environmental inputs that moves those same clocks the other way. The rejuvenation field builds machinery to run the clock backward. I built the standard for the input that runs it forward. Same axis, opposite ends.
The clock, wound forward
The clocks the reprogramming field resets have names: Horvath, Hannum, PhenoAge, GrimAge. They are the same clocks heavy metals move.
Start with the cleanest population data. In a nationally representative sample of U.S. adults aged 50 and older, blood lead and cadmium were associated with faster epigenetic aging across Hannum, GrimAge, GrimAge2, and PhenoAge, after adjustment for demographics, lifestyle, comorbidity, and blood-cell composition. An exposome-wide scan of the same survey put a number on it: a one-standard-deviation increase in serum cadmium tracked with 1.23 years of GrimAge acceleration, and the association survived adjustment for cotinine, the biomarker of tobacco smoke. That makes it a dietary signal in its own right, separable from smoking. The Strong Heart Study reproduced the pattern in a different population, with cadmium the standout metal and the association stronger in people who never smoked.
Then the endpoint that matters. In a cohort linking urinary metals, epigenetic clocks, and death, epigenetic aging measures statistically accounted for 43 to 46 percent of the relationship between cadmium and mortality risk. Epigenetic aging sits on the causal path between the exposure and the grave, carrying close to half of the measured effect.
Let me be precise about the weight of that evidence. It is observational, cross-sectional in places, and it demonstrates association rather than a proven causal effect on human lifespan. It is also consistent across cohorts, dose-responsive, robust to smoking adjustment, and mechanistically coherent, which is about as much as human environmental epidemiology ever offers before someone decides to act on it.
Diet is the input, which is where a standard lives
For a non-smoker, diet is the dominant source of cadmium, on the order of 90 percent of intake. European food-safety regulators trace most of it to the ordinary middle of the plate: cereals and grains, leafy and root vegetables, potatoes, nuts and pulses, and organ meats, with cocoa and shellfish concentrating it further. This is lunch, eaten for decades.
Decades is the operative word. Cadmium has a biological half-life in the kidney measured in 10 to 30 years; the body banks it like a slow deposit that barely pays out. Every year of lower intake means a smaller lifetime burden, which is exactly the kind of variable a food standard can move. Chelation after the fact carries its own risks and no guarantee of clearing the deposit. Lowering the dose going in, meal after meal, year after year, is the safer lever, and it is the one a certification standard controls. I have spent fifteen years turning problems of that shape into auditable limits.
The mechanism is inside the reaction
Here is the part a metallomics reading sees and a pure cell-biology reading can walk straight past. The reprogramming reaction and the aging clock both run on metalloenzymes.
The eraser that partial reprogramming depends on is the TET family of dioxygenases, which strip methyl marks off DNA. TET enzymes are iron(II)- and 2-oxoglutarate-dependent oxygenases; iron sits in the active site and does the chemistry. That dependence is load-bearing. When Sinclair's group reversed vision in mice, the benefit of OSK required TET1 and TET2; remove the iron-dependent demethylases and the rejuvenation stops happening. The histone-side erasers, the JmjC demethylases, belong to the same iron and 2-oxoglutarate class. And KLF4, the K in Yamanaka's cocktail, is itself a zinc-finger transcription factor. The tools of rejuvenation are, chemically, metal-dependent proteins.
Now put cadmium in that cell. Cadmium's signature toxicity is ionic mimicry: it slides into zinc's coordination sites and sits there without doing zinc's job. In DNA-repair proteins the mapping is detailed. Cadmium displaces zinc in the zinc-finger repair proteins XPA and Fpg, and it swaps into the zinc hook of Rad50, destabilizing the complex that senses double-strand breaks. A cell carrying a cadmium burden runs its epigenetic and repair machinery in a buffer where the wrong metal keeps occupying the right seats. Reset the methylation clock in that cell and you have refreshed a readout while leaving the chemistry that corrupts it in place.
The organism the cell still lives in
A reprogrammed cell does not float in buffer. It sits in an organism that keeps eating, keeps banking cadmium on that decades-long half-life, and carries a gut microbiome that helps set how much metal is absorbed, retained, and biotransformed. The microbiome is itself an aging variable, and it modulates host metal toxicokinetics, the interface I work on as microbial metallomics. That is the systems question the cell-level story leaves out: whether a rejuvenated state holds up in a body that is still winding its own clock forward, one contaminated meal at a time. You can reset a cell in a dish. Keeping it young inside a person is a whole-organism problem, and metal exposure is one of its terms.
Certification as a longevity intervention
Which is where certification stops being only a food-safety story and becomes a longevity one.
Nobody can buy reprogramming yet; the first trial is a safety study in the eye. What is available today, at the scale of a whole food supply, is control of the input. That is the entire job of Heavy Metal Tested & Certified (HMTc): category-specific limits built on ALARA principles, independent third-party testing, and a public evidence index underneath the seal so the standard can be argued with instead of trusted on faith. I have written elsewhere about how that pipeline actually gets built and what operating without it costs.
Here is the framing I want on the record. When a product certifies against a heavy-metal standard, the visible result is a mark on a package and a lower number on a lab report. The byproduct is that everyone who eats it takes in less of one of the best-documented dietary accelerants of epigenetic age, for years, without changing anything else about how they live. The rejuvenation field works downstream, resetting damage after it accrues. Certification works upstream, lowering the dose that does the accruing. Anyone planning to buy a reset in 2032 should want low-gerontogen food in 2026, because you do not pay to run a clock backward and then keep feeding the thing that runs it forward.
Life extension, in this framing, is a byproduct of certification. The seal itself stays modest and testable in what it claims. The downstream consequence is the larger thing: lowering a population's lifetime metal burden means less epigenetic age acceleration, spread across everyone who eats the certified product, at a cost per person no clinical therapy will approach this decade.
Two honest caveats
Because the standard I hold my own field to applies here.
First, the causal claim. No randomized trial has shown that lowering dietary cadmium slows a human epigenetic clock or extends human life; that trial would run for decades and probably never be funded cleanly. The mechanism is established, the epidemiology is consistent across cohorts, and the inference is reasonable and testable. It remains an inference until a trial closes it, and I will say so plainly until one does.
Second, the company this topic keeps. The science travels alongside a great deal of supplement marketing that borrows its vocabulary: peptide "bioregulators" like Epitalon sold as epigenetic reprogramming on the strength of small or preclinical work. A 2026 systematic review collected the interventions shown to lower a next-generation epigenetic clock in humans across 41 studies; the entries are unglamorous, and the injectable with the strongest randomized signal is semaglutide, a licensed GLP-1 drug. The bioregulator peptides sold for the job have no comparable human trial. And the grey-market vials that carry them have a heavy-metal problem of their own: independent testing keeps turning up lead and arsenic as synthesis residues, invisible to the HPLC-UV certificates the vendors provide. An unverified market with no published-limits benchmark is the next place a heavy-metal standard belongs.
The disagreement, if there is one
The longevity industry has decided that biological age is an engineering target. I agree with them. The only open question is where the cheapest intervention sits. Theirs rides in a viral vector delivered to the eye, brilliant and years from your kitchen. Mine sits in the limits printed on a package, boring and available now. Both act on the same clock. One of them, you can start using at your next meal.
Karen Pendergrass is the founder of the Paleo Foundation and the developer of the HMTc heavy-metal certification framework. Related reading: the biology under the standard in microbial metallomics, the build in from evidence to certification, and the stakes in what no certification costs.